West Announces Second-Quarter Dividend
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST) has announced its second-quarter 2025 dividend payment. The company's Board of Directors has approved a dividend of $0.21 per share, which will be paid on May 7, 2025, to shareholders of record as of April 30, 2025. West Pharmaceutical Services is recognized as a global leader in innovative solutions for injectable drug administration.
Positive
- Consistent dividend payment demonstrates financial stability
- Maintains shareholder returns through quarterly dividend program
Negative
- None.
News Market Reaction
On the day this news was published, WST gained 3.56%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-second-quarter-dividend-302381862.html
SOURCE West Pharmaceutical Services, Inc.